LABORATORY CORPORATION OF AMERICA HOLDINGS

Laboratory Corporation of America Holdings

LH

US50540R4092

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 04:00:02 2024-05-06 pm EDT			5-day change	1st Jan Change
201 ^USD	-0.14%		-1.53%	-11.55%

Apr. 30	Tranche Update on Laboratory Corporation of America Holdings (NYSE:LH)'s Equity Buyback Plan announced on December 9, 2021.	CI
Apr. 30	Baird Adjusts Laboratory Corp of America Holdings' Price Target to $255 From $244	MT

Laboratory Corporation of America Holdings(NYSE:LH) dropped from Russell 1000 Growth Index

June 25, 2021 at 12:00 am EDT

Latest news about Laboratory Corporation of America Holdings

Tranche Update on Laboratory Corporation of America Holdings (NYSE:LH)'s Equity Buyback Plan announced on December 9, 2021.	Apr. 30	CI
Baird Adjusts Laboratory Corp of America Holdings' Price Target to $255 From $244	Apr. 30	MT
Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy	Apr. 29	MT
US FDA publishes final rule for laboratory developed tests	Apr. 29	RE
Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B	Apr. 29	CI
Baird Adjusts Laboratory Corp of America Holdings' Price Target to $244 From $255	Apr. 26	MT
Barclays Adjusts Price Target on Laboratory Corp of America Holdings to $213 From $234	Apr. 26	MT
Truist Cuts Price Target on Laboratory Corp of America Holdings to $255 From $270, Keeps Buy Rating	Apr. 26	MT
Evercore ISI Cuts Laboratory Corp of America Holdings' Price Target to $210 From $225	Apr. 25	MT
Leerink Partners Adjusts Laboratory Corp of America Price Target to $242 From $260, Keeps Outperform Rating	Apr. 25	MT
Laboratory Corp of America Q1 Adjusted Earnings, Revenue Increase; 2024 Adjusted EPS Outlook Updated	Apr. 25	MT
Transcript : Laboratory Corporation of America Holdings, Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25
Earnings Flash (LH) LABORATORY CORPORATION OF AMERICA HOLDINGS Reports Q1 Revenue $3.18B, vs. Street Est of $3.12B	Apr. 25	MT
Earnings Flash (LH) LABORATORY CORPORATION OF AMERICA HOLDINGS Reports Q1 EPS $3.68, vs. Street Est of $3.48	Apr. 25	MT
Laboratory Corporation of America Holdings Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Labcorp beats quarterly estimates on strong testing demand	Apr. 25	RE
North American Morning Briefing : More Tech -2-	Apr. 25	DJ
Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln	Apr. 24	RE
Laboratory Corporation of America Holdings Announces Winning Bid for Select Assets of Invitae	Apr. 24	CI
Laboratory Corporation of America Holdings (NYSE:LH) won the bid to acquire substantially all of the assets of Invitae Corporation for approximately $240 million.	Apr. 23	CI
Laboratory Corporation of America Holdings (NYSE:LH) agreed to acquire Substantially all Assets of Invitae Corporation (OTCPK:NVTA.Q).	Apr. 23	CI
Labcorp Introduces Test for Early Detection of Neurodegenerative Diseases	Apr. 15	MT
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw	Apr. 15	CI
Labcorp Keeps Quarterly Dividend at $0.72 Per Share, Payable June 12 to Stockholders of Record May 28	Apr. 11	MT
Labcorp Declares Quarterly Dividend, Payable on June 12, 2024	Apr. 11	CI

Chart Laboratory Corporation of America Holdings

Duration

Period

Chart Laboratory Corporation of America Holdings

More charts

Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows: - clinical laboratory services (63.9%): routine testing, patient diagnosis, disease monitoring and treatment, and other services; - development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies. Net sales are distributed geographically as follows : North America (81.2%), Europe (12.7%) and other (6.1%).

Sector

Healthcare Facilities & Services

Calendar

2024-05-14 - Annual General Meeting

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Laboratory Corporation of America Holdings

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

201.3 USD

Average target price

239.6 USD

Spread / Average Target

+19.01%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
LABORATORY CORPORATION OF AMERICA HOLDINGS	-11.55%	16.97B
HCA HEALTHCARE, INC.	+14.55%	80.61B
CVS HEALTH CORPORATION	-29.12%	70.18B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+11.76%	29.12B
FRESENIUS SE & CO. KGAA	-0.71%	16.96B
QUEST DIAGNOSTICS INCORPORATED	-1.62%	15.26B
FRESENIUS MEDICAL CARE AG	+4.35%	12.41B
PURE HEALTH HOLDING	-30.88%	11.95B
REDE D'OR SÃO LUIZ S.A.	-5.53%	11.93B
NATERA, INC.	+55.19%	11.85B

Other Healthcare Facilities & Services